Presentation TCT 2018 New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability Presenter: Michael J. Mack, Bernard Prendergast, Davide Capodanno September 22, 2018
Presentation TCT 2018 The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies Presenter: Michael J. Mack, Bernard Prendergast, Lars Sondergaard September 22, 2018
Presentation TCT 2018 MR and TR Valve Related Device Will be a Game Changer? -From Japanese Academias Prospective Based on Post-Market Surveillance in Japan Presenter: Philippe Genereux, Shigeru Saito, Makoto Amaki September 22, 2018
Presentation TCT 2018 To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures Presenter: Michael J. Mack, Bernard Prendergast, Adam B. Greenbaum September 22, 2018
Presentation TCT 2018 MR and TR Valve Related Device Will be a Game Changer? -From US Academias Prospective Presenter: Philippe Genereux, Shigeru Saito September 22, 2018
Presentation TCT 2018 To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures Presenter: Michael J. Mack, Bernard Prendergast, Adnan K. Chhatriwalla September 22, 2018
Presentation TCT 2018 The Current Situation and Trend for the MR and TR Valve Related Devices Presenter: Philippe Genereux, Shigeru Saito, Fumiaki Ikeno September 22, 2018
Presentation TCT 2018 How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures Presenter: Michael J. Mack, Bernard Prendergast, Philipp Blanke September 22, 2018
Presentation TCT 2018 Clinical Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes Presenter: Michael J. Mack, Bernard Prendergast, John G. Webb September 22, 2018
Presentation TCT 2018 Global Early Feasibility Study: Novel Mitral Regurgitation Valve Treatment Device Presenter: Philippe Genereux, Shigeru Saito, Robert J Thatcher September 22, 2018
Presentation TCT 2018 Status Update of the TAVR UNLOAD Trial Moderate AS Patients with Reduced Ejection Fraction and Heart Failure Presenter: Allan Schwartz, Stephan Windecker, Joost Daemen September 22, 2018
Presentation TCT 2018 Putting It All Together: A Proposed New Staging Classification for Patients with Aortic Stenosis Presenter: Philippe Genereux September 22, 2018
Presentation TCT 2018 Who Should be Treated? The Role of Biomarkers in Patient Selection and Procedure Optimization Presenter: Eric Van Belle September 22, 2018
Presentation TCT 2018 Comprehensive Solution for Tricuspid Regurgitation and RV Dysfunction: Trisol Medical Presenter: Louis A. Cannon, Juan F. Granada, Giora Weisz September 22, 2018
Presentation TCT 2018 Who Should be Treated? The Role of Imaging Guidance in Patient Selection Presenter: Philippe Pibarot September 22, 2018
Presentation TCT 2018 Rationale for Treating SASS and Update of the EARLY-TAVR Trial Presenter: Allan Schwartz September 22, 2018
Presentation TCT 2018 My Crystal Ball - Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis Once the Cycle of Low-Risk Studies is Completed Presenter: Allan Schwartz, Stephan Windecker, Michael J. Reardon September 22, 2018
Presentation TCT 2018 The Case for TAVR in Low-Risk Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials Presenter: Allan Schwartz, Stephan Windecker, Jeffrey J. Popma September 22, 2018
Presentation TCT 2018 TCT-7: Predictors and Outcomes of Aborted Procedures During Elective Transcatheter Aortic Valve Replacement Presenter: Steven R. Bailey, Patrick W. Serruys, Jennifer Rymer September 22, 2018
News Conference News TCT 2018 Novel LAA Closure Device Shows Promise in Early Experience L.A. McKeown September 22, 2018